Gujarat Kidney

INR
101.60
-0.2 (-0.2%)
BSENSE

Mar 30

BSE+NSE Vol: 4.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Net Sales
51.44
30.46
Other Operating Income
0.00
0.00
Total Operating income
51.44
30.46
Raw Material Cost
5.74
2.40
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
8.29
6.36
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
16.76
7.77
Total Expenditure (Excl Depreciation)
30.79
16.53
Operating Profit (PBDIT) excl Other Income
20.65
13.93
Other Income
0.16
0.10
Operating Profit (PBDIT)
20.81
14.03
Interest
1.06
0.49
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
19.75
13.54
Depreciation
3.19
2.39
Profit Before Tax
16.55
11.16
Tax
4.56
3.00
Provisions and contingencies
0.00
0.00
Profit After Tax
11.99
8.17
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
11.99
8.17
Share in Profit of Associates
0.00
0.00
Minority Interest
-0.01
0.03
Other related items
0.00
0.00
Consolidated Net Profit
10.45
8.13
Equity Capital
11.37
11.37
Face Value
2.0
2.0
Reserves
0.00
0.00
Diluted Earnings per share
0.52
0.01
Operating Profit Margin (Excl OI)
40.14%
45.73%
Gross Profit Margin
38.39%
44.45%
PAT Margin
23.31%
26.82%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
Markets Mojo
Analysis not available as Data has been published for only 1 period
Compare Nine Monthly Results Of Gujarat Kidney With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
51.44
0
51.44
Other Operating Income
0.00
0.00
0.00
Total Operating income
51.44
0
51.44
Raw Material Cost
5.74
0
5.74
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.00
0
0.00
Employee Cost
8.29
0
8.29
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
16.76
0.00
16.76
Total Expenditure (Excl Depreciation)
30.79
0
30.79
Operating Profit (PBDIT) excl Other Income
20.65
0.00
20.65
Other Income
0.16
0
0.16
Operating Profit (PBDIT)
20.81
0
20.81
Interest
1.06
0
1.06
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
19.75
0
19.75
Depreciation
3.19
0
3.19
Profit Before Tax
16.55
0
16.55
Tax
4.56
0
4.56
Provisions and contingencies
0.00
0
0.00
Profit After Tax
11.99
0
11.99
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
11.99
0
11.99
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.01
0
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.45
0
10.45
Equity Capital
11.37
0
11.37
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
38.39%
0%
0.00
38.39%
PAT Margin
23.31%
0%
0.00
23.31%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 30.85 Cr
in Dec 2025

Figures in Cr
stock-summary

Nine Monthly - Standalone Net Profit
Standalone Net Profit 8.53 Cr
in Dec 2025

Figures in Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.56 Cr
in Dec 2025

Figures in Cr
Nine Monthly - Interest
Interest 0.65 Cr
in Dec 2025

Figures in Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 47.20%
in Dec 2025

Figures in %